Cargando…
Iatrogenic Cushing’s Syndrome: The Result of Cobicistat and Glucocorticoid Interaction in an HIV Patient After Bariatric Surgery
Cobicistat, used as a pharmacokinetic booster in therapeutic combination with human immunodeficiency virus (HIV) protease inhibitors and integrase inhibitors, is a strong inhibitor of cytochrome P450 3A4 (CYP3A4). Since most glucocorticoids are metabolized by the isoenzyme of the cytochrome P450 pat...
Autores principales: | Benido Silva, Vânia, Cardoso, Joana, Esteves Brandão, Maria, Mesquita, Isabel, Pereira, Maria Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975894/ https://www.ncbi.nlm.nih.gov/pubmed/36874659 http://dx.doi.org/10.7759/cureus.34367 |
Ejemplares similares
-
Six-Year Complete Remission of Type-1 Diabetes Mellitus in an Adult Treated With Sitagliptin
por: Benido Silva, Vânia, et al.
Publicado: (2023) -
Iatrogenic Cushing’s From Celiac Plexus Blocks for Chronic Pancreatitis: A Case Report
por: Tagliaferri, Ariana R, et al.
Publicado: (2023) -
Avascular Necrosis of Both Hips From Iatrogenic Cushing ’s Syndrome due to Coadministration of Fluticasone and Ritonavir in an HIV-Infected Patient
por: Kant, Ravi, et al.
Publicado: (2020) -
A Rare Case of Thoracoabdominal Paraganglioma: A Case Report and Literature Review
por: Baptista, Patrícia, et al.
Publicado: (2022) -
SAT331 A Case Of Iatrogenic Cushing’s Syndrome Due To The Concomitant Use Of Cobicistat With An Inhaled Glucocorticoid Followed By Adrenal Insufficiency Upon Discontinuation Of Cobicistat
por: Noor, Laila, et al.
Publicado: (2023)